Accelerated Approval: US FDA’s Hammer Falls On Oncopeptides’ Pepaxto

 
• By Sue Sutter
  
Hammer on glass
The Pepaxto NDA must be withdrawn, Peter Marks said in a final order. • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews